| 发明名称 |
HLA-A24 binding cancer antigen peptide derived from livin |
| 摘要 |
The present invention provides a partial peptide consisting of 8-11 contiguous amino acids in the amino acid sequence of livin set forth in SEQ ID NO: 1, which binds to HLA-A24 antigen and is recognized by cytotoxic T cells (CTLs), a polynucleotide encoding the peptide, and cancer vaccine comprising the peptide or the polynucleotide.
|
| 申请公布号 |
US7601801(B2) |
申请公布日期 |
2009.10.13 |
| 申请号 |
US20040563916 |
申请日期 |
2004.07.07 |
| 申请人 |
DAINIPPON SUMITOMO PHARMA CO., LTD. |
发明人 |
SATO NORIYUKI;TORIGOE TOSHIHIKO;HARIU HIROYUKI;HIROHASHI YOSHIHIKO |
| 分类号 |
C07K16/00;A61K38/00;A61K38/17;A61K39/00;A61P35/00;C07K7/06;C07K14/47;C07K16/28;C12N1/15;C12N1/19;C12N1/21 |
主分类号 |
C07K16/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
